发明申请
- 专利标题： MUSCARINIC ACETYLCHOLINE RECEPTOR SUBTYPE 4 ANTAGONISTS IN THE TREATMENT OF ANEMIA
-
申请号： US17442926申请日： 2020-03-20
-
公开(公告)号： US20220185821A1公开(公告)日： 2022-06-16
- 发明人: Yousef AL ABED , Lingbo ZHANG
- 申请人： COLD SPRING HARBOR LABORATORY , THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
- 申请人地址： US NY Cold Spring Harbor; US NY Manhasset
- 专利权人： COLD SPRING HARBOR LABORATORY,THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
- 当前专利权人： COLD SPRING HARBOR LABORATORY,THE FEINSTEIN INSTITUTES FOR MEDICAL RESEARCH
- 当前专利权人地址： US NY Cold Spring Harbor; US NY Manhasset
- 国际申请： PCT/US20/23989 WO 20200320
- 主分类号： C07D498/14
- IPC分类号： C07D498/14 ; C07D401/06
摘要：
This disclosure generally relates to treating anemias. More specifically, the disclosure relates to use of muscarinic acetylcholine receptor subtype 4 antagonists, such as small molecule compounds, to promote self-renewal of burst forming unit erythroid (BFU-E) cells and treat anemias.
信息查询
